Microbial Chemistry Research Foundation
USPTO PatentsView assignee record - 28 granted patents across 21 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Microbial ranks #11,006 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 21 technology areas.
- #11,006
- of 49,997 US assignees by volume
- 38th percentile
- by Innovation Score (31.6/100)
- 6.3
- avg claims per patent
- -83%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R11006 · Foreign Corporation #11,006 · 28 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 28 grants
- UPPER-Q #11,006/49,997
- PHOTO-FINISH Maxcyte
- CPC-FOCUS A61P · 21 areas
- INNOV-THIN 31.6/100
- CLAIMS-SPARSE 6.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -83% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Maxcyte, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Microbial’s 31.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Microbial
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Formosa Epitaxy… · near 32
Formosa Epitaxy… · near
32 score
- Korloy · near 32
Korloy · near
32 score
- Microbial Chemistry… · this assignee 32
Microbial Chemistry… · this assignee
32 score
- Research & Design… · near 32
Research & Design… · near
32 score
- Scaleflux · near 32
Scaleflux · near
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Microbial's Innovation Score is 31.6/100 (38th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Microbial?
Each dot is one of Microbial’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Microbial’s own 6.3 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Microbial's grants concentrate
Microbial Chemistry Research Foundation is a focused PatentsView assignee: 21 CPC subclasses with 57.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (8 grants) versus a trough of 2 in 2019. By volume, Microbial sits between Maxcyte, Inc. and Multinarity Ltd.
Who files at Microbial's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Maxcyte
Maxcyte, Inc.
28 patents
- Mckinsey &
Mckinsey & Company, Inc.
28 patents
- Medrx
Medrx Co., Ltd.
28 patents
- MHI Vestas Offsho…
MHI Vestas Offshore Wind A/S
28 patents
- Mineral Earth Sci…
Mineral Earth Sciences LLC
28 patents
- Mizkan Holdings
Mizkan Holdings Co., Ltd.
28 patents
- Moldino Tool Engi…
Moldino Tool Engineering, Ltd.
28 patents
- Multinarity
Multinarity Ltd
28 patents
- Microbial Chemist… ◀
Microbial Chemistry Research Foundation
28 patents
What this shows Microbial holds 28 patents at rank #10,997, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Microbial
By rank, the assignees closest to #10,997 in granted patent volume.
- Maxcyte, Inc. #10,993 · 28 patents
- Mckinsey & Company, Inc. #10,994 · 28 patents
- Medrx Co., Ltd. #10,995 · 28 patents
- MHI Vestas Offshore Wind A/S #10,996 · 28 patents
- Mineral Earth Sciences LLC #10,998 · 28 patents
- Mizkan Holdings Co., Ltd. #10,999 · 28 patents
- Moldino Tool Engineering, Ltd. #11,000 · 28 patents
- Multinarity Ltd #11,001 · 28 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Microbial's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Microbial, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Microbial ranks #1,230 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (32 here).
Microbial's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 38th percentile higher than 38% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 25.0% |
| 2016 | 8 | 28.6% |
| 2017 | 3 | 10.7% |
| 2018 | 4 | 14.3% |
| 2019 | 2 | 7.1% |
| 2020 | 2 | 7.1% |
| 2021 | 2 | 7.1% |
Which technologies does Microbial Chemistry Research Foundation patent most?
Top 15 of 21 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Microbial Chemistry Research Foundation's patent record in context - here's where to go next.
- Microbial Chemistry Research Foundation's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 57.1% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #11,006 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Microbial Chemistry Research Foundation against Maxcyte, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.